Heart transplant breakthrough? OCS device Follow-Up study tracks 5-Year survival
NCT ID NCT05741723
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 276 heart transplant patients who received a donor heart preserved with the OCS Heart device. Researchers will track survival and other outcomes for up to 5 years after transplant. The goal is to confirm the long-term safety and effectiveness of using OCS-preserved hearts for transplantation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OCS Heart device (preserves donor hearts for transplant)
What this could lead to
If successful, this study could confirm that OCS-preserved hearts are safe and effective for transplantation, potentially increasing the donor heart supply.
What could go wrong
This is a follow-up study, not a new treatment test. It only observes outcomes in already transplanted patients, so it cannot prove new benefits or safety beyond what is already known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando
Orlando, Florida, 32803, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Emory University Hospital
Atlanta, Georgia, 30322, United States
-
Froedtert & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Minneapolis Heart Institute
Minneapolis, Minnesota, 55407, United States
-
Montefiore
The Bronx, New York, 10467, United States
-
Northwestern Medicine
Chicago, Illinois, 60611, United States
-
Nyph/Cumc
New York, New York, 10032, United States
-
Sentara
Norfolk, Virginia, 23502, United States
-
St. Vincent Cardiovascular Research Institute
Indianapolis, Indiana, 46260, United States
-
Stanford University
Palo Alto, California, 94304, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
University of California San Diago
La Jolla, California, 92037, United States
-
University of Minnesota
Minneapolis, Minnesota, 55414, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Vanderbilt Medical Center
Nashville, Tennessee, 37232, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States